Answer:
Hemostatic agents can help save lives at the scene of accidents, fires, & other emergencies.
There are sponges that conform to the shape of the wound and powders that absorb the blood with in an injury.
Several hemostatic agents have received both U.S. food and drug administration (FDA) approval and the conformite europeenne (CE) approval for external use in trauma settings. Among these are QuikClot, one of the first agents to receive FDA approval for external use in 2002 and its later form QuikClot ACS+ (approved in July 2006, produced by the same company), self-expanding hemostatic polymer (SEHP), HemCon, Celox, modified rapid deployment hemostat (mRDH) (Marine Polymer Technologies Inc., Danvers, MA, USA), WoundStat (TraumaCure Inc. Bethesda, MD, USA), CombatGauze (Z-Medica, Newington, C, USA), FastAct/SeraSeal (Wortham Labs Inc., Chattanooga, TN, USA), and TraumaDex.
Antifibrinolytic drugs promote blood clotting by preventing blood clots from breaking down.
Some examples of antifibrinolytic drugs are aprotinin, tranexamic acid (TXA), epsilon-aminocaproic acid and aminomethylbenzoic acid.
Doctors sometimes give these drugs to patients having surgery to prevent blood loss.
Step-by-step explanation:
When in doubt, or while you are waiting for hemostatic agents to be applied by trained professionals remember to provide direct pressure and elevate the wound ( if it is a limb).
Hemorrhagic shock, resulting from trauma, continues to be the major cause of mortality during combat, and the second most common cause of death in civilian trauma centers . The primary goal in emergency conditions should be the rapid establishment of an effective hemostasis.. Topical hemostasis is defined as a process that acts to locally stop the bleeding from damaged blood vessels . This process takes place in several sequential steps that include the constriction of blood vessels, the activation of the coagulation cascade, and the formation of blood clots.